Insmed to Present New Data from Across its Respiratory Portfolio at the American Thoracic Society 2024 International Conference

/PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare...

Related Keywords

New Jersey ,United States ,Japan ,San Diego ,California ,Japanese ,American ,Eleanor Barisser ,Martina Flammer ,Pharma Gmb ,Bryan Dunn ,Mandy Fahey ,Corporate Communications ,Regional Poison Control Center ,International Conference ,Company Annual Report On Form ,Prnewswire Insmed Incorporated Nasdaq ,Exchange Commission ,Insmed Incorporated ,American Thoracic Society ,Additional Data ,Microbiologic Outcomes ,Newly Diagnosed ,Patient Reported Respiratory Symptoms ,Chief Medical Officer ,Nebuliser Dispersion ,Nebulizer System ,Hypersensitivity Reactions ,Fetal Toxicity ,Common Adverse Reactions ,Full Prescribing ,Private Securities Litigation Reform Act ,Pharmakon Advisors ,Orbimed Royalty ,Annual Report ,